Skip to main content
. 2012 Nov 13;31(1):172–178. doi: 10.3892/ijmm.2012.1179

Figure 3.

Figure 3

CD11b and NeuN immunoreactivity at 7 days after pMCAO. (A) CD11b immunoreactivity in the brain of the PJ34-treated rats is markedly attenuated compared with the vehicle-treated rats (x400); *P<0.05 vs. the vehicle group. (B) The PJ34-treated rats (right) show fewer NeuN-positive cells in the peri-necrotic cortex than the vehicle-treated rats (left), (x400). (C) There was a significant difference in the number of NeuN staining cells between the PJ34- and vehicle-treated rats; *P<0.05 vs. the vehicle group.